These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29184840)

  • 1. Personalized medicine: An era of dosage form development.
    Nagaich U
    J Adv Pharm Technol Res; 2017; 8(4):115. PubMed ID: 29184840
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperthyroidism in the personalized medicine era: the rise of mathematical optimization.
    Meng F; Li E; Yen PM; Leow MKS
    J R Soc Interface; 2019 Jun; 16(155):20190083. PubMed ID: 31238837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.
    Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG
    Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D Printing in Personalized Drug Delivery.
    Afsana ; Jain V; Haider N; Jain K
    Curr Pharm Des; 2018; 24(42):5062-5071. PubMed ID: 30767736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical student preparedness for an era of personalized medicine: findings from one US medical school.
    Eden C; Johnson KW; Gottesman O; Bottinger EP; Abul-Husn NS
    Per Med; 2016 Mar; 13(2):129-141. PubMed ID: 27528879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and personalized medicine: a focus on kidney disease.
    Siwy J; Mischak H; Zürbig P
    Expert Rev Proteomics; 2019 Sep; 16(9):773-782. PubMed ID: 31441341
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostics for personalized medicine: what will change in the era of large-scale genomics studies?
    Grewal A; Stephan DA
    Per Med; 2013 Nov; 10(8):835-848. PubMed ID: 29776283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.
    Malentacchi F; Mancini I; Brandslund I; Vermeersch P; Schwab M; Marc J; van Schaik RH; Siest G; Theodorsson E; Pazzagli M; Di Resta C; ;
    Clin Chem Lab Med; 2015 Jun; 53(7):981-8. PubMed ID: 25995323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new era of personalized medicine: 10 years later.
    Jørgensen JT; Winther H
    Per Med; 2009 Jul; 6(4):423-428. PubMed ID: 29783540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.
    Malentacchi F; Mancini I; Brandslund I; Vermeersch P; Schwab M; Marc J; van Schaik RH; Siest G; Theodorsson E; Pazzagli M; Di Resta C;
    Drug Metab Pers Ther; 2015 Jun; 30(2):121-8. PubMed ID: 26036226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonstandard personalized medicine strategies for cancer may lead to improved patient outcomes.
    Beckman RA; Yeang CH
    Per Med; 2014 Sep; 11(7):705-719. PubMed ID: 29764056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights of Miami winter symposium 2015: into the era of immunotherapy.
    Zhou W
    Cancer Biol Med; 2015 Mar; 12(1):68-9. PubMed ID: 25859415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A call to action: training pathology residents in genomics and personalized medicine.
    Haspel RL; Arnaout R; Briere L; Kantarci S; Marchand K; Tonellato P; Connolly J; Boguski MS; Saffitz JE
    Am J Clin Pathol; 2010 Jun; 133(6):832-4. PubMed ID: 20472839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating genomics and neuromarkers for the era of brain-related personalized medicine.
    Gordon E
    Per Med; 2007 May; 4(2):201-215. PubMed ID: 29788634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An appraisal of drug development timelines in the Era of precision oncology.
    Jardim DL; Schwaederle M; Hong DS; Kurzrock R
    Oncotarget; 2016 Aug; 7(33):53037-53046. PubMed ID: 27419632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future may be closer than you think: a response from the Personalized Medicine Coalition to the Royal Society's report on personalized medicine.
    Ginsburg GS; Angrist M
    Per Med; 2006 May; 3(2):119-123. PubMed ID: 29793285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine: reality and reality checks.
    Leeder JS; Spielberg SP
    Ann Pharmacother; 2009 May; 43(5):963-6. PubMed ID: 19417116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.